disseminated Neuroblastoma (NB) (DBCOND0153551)

Identifiers

Synonyms

Disseminated Neuroblastoma

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Cyclophosphamide	A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.	DNAtarget Cytochrome P450 2B6enzyme Cytochrome P450 2C9enzyme Cytochrome P450 3A4enzyme Cytochrome P450 2C19enzyme Cytochrome P450 2A6enzyme Cytochrome P450 2C18enzyme Cytochrome P450 2C8enzyme Cytochrome P450 3A5enzyme Nuclear receptor subfamily 1 group I member 2target

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00093821	Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors	Tanespimycin	treatment	1	completed
NCT01558778	Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant	No drug interventions	supportive_care	Not Available	withdrawn
NCT01484015	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia	Cefepime	treatment	1	completed
NCT01305200	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant	Calcium Phosphate	supportive_care	3	completed
NCT01358617	Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma	No drug interventions	Not Available	Not Available	completed
NCT00028522	R(+)XK469 in Treating Patients With Advanced Neuroblastoma	No drug interventions	treatment	1	completed
NCT01159067	Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload	Deferasirox	supportive_care	2	terminated
NCT00060372	Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer	Ipilimumab Therapeutic allogeneic lymphocytes	treatment	1	completed
NCT00408681	Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant	Lithium carbonate	supportive_care	Not Available	completed
NCT00799461	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications	No drug interventions	supportive_care	3	completed
NCT02173093	Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma	Aldesleukin Sargramostim	treatment	1 / 2	unknown_status
NCT00309907	Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant	Etanercept Methylprednisolone Methylprednisolone hemisuccinate	treatment	2	completed
NCT00436852	ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment	ABT-751	treatment	2	completed
NCT00005576	Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma	Aldesleukin Dinutuximab Isotretinoin Sargramostim	treatment	1	completed
NCT00898391	Study of DNA in Blood Samples From Patients With Neuroblastoma	No drug interventions	Not Available	Not Available	completed
NCT00795769	Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant	Ondansetron	supportive_care	2	completed
NCT00053950	Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma	Filgrastim Pyrazoloacridine	treatment	1	terminated